ResMed (RMD) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Macquarie Upgrades ResMed (RMD) to Neutral
April 28, 2016 7:08 AM EDTMacquarie upgraded ResMed (NYSE: RMD) from Underperform to Neutral.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $56.65 yesterday.
... MorePiper Jaffray Downgrades ResMed (RMD) to Neutral
April 27, 2016 6:37 AM EDTPiper Jaffray downgraded ResMed (NYSE: RMD) from Overweight to Neutral with a price target of $57.00 (from $65.00).
Analyst Matt O'Brien commented, "We are downgrading RMD to Neutral from Overweight and lowering our PT to $57 from $65. The genesis of our downgrade is that we believe headwinds and the lack of near term... More
